253 related articles for article (PubMed ID: 35456894)
21. Failure of protein quality control in amyotrophic lateral sclerosis.
Kabashi E; Durham HD
Biochim Biophys Acta; 2006; 1762(11-12):1038-50. PubMed ID: 16876390
[TBL] [Abstract][Full Text] [Related]
22. A Novel Potentially Pathogenic Rare Variant in the
Wang M; Liu Z; Yuan Y; Ni J; Li W; Hu Y; Liu P; Hou X; Huang L; Jiao B; Shen L; Jiang H; Tang B; Wang J
Front Genet; 2020; 11():821. PubMed ID: 33193563
[TBL] [Abstract][Full Text] [Related]
23. [Prion-like Properties of Misfolded Cu/Zn-superoxide Dismutase in Amyotrophic Lateral Sclerosis: Update and Perspectives].
Tokuda E; Marklund SL; Furukawa Y
Yakugaku Zasshi; 2019; 139(7):1015-1019. PubMed ID: 31257248
[TBL] [Abstract][Full Text] [Related]
24. TDP-43 or FUS-induced misfolded human wild-type SOD1 can propagate intercellularly in a prion-like fashion.
Pokrishevsky E; Grad LI; Cashman NR
Sci Rep; 2016 Mar; 6():22155. PubMed ID: 26926802
[TBL] [Abstract][Full Text] [Related]
25. TNF receptor-associated factor 6 interacts with ALS-linked misfolded superoxide dismutase 1 and promotes aggregation.
Semmler S; Gagné M; Garg P; Pickles SR; Baudouin C; Hamon-Keromen E; Destroismaisons L; Khalfallah Y; Chaineau M; Caron E; Bayne AN; Trempe JF; Cashman NR; Star AT; Haqqani AS; Durcan TM; Meiering EM; Robertson J; Grandvaux N; Plotkin SS; McBride HM; Vande Velde C
J Biol Chem; 2020 Mar; 295(12):3808-3825. PubMed ID: 32029478
[TBL] [Abstract][Full Text] [Related]
26. Using yeast models to probe the molecular basis of amyotrophic lateral sclerosis.
Bastow EL; Gourlay CW; Tuite MF
Biochem Soc Trans; 2011 Oct; 39(5):1482-7. PubMed ID: 21936838
[TBL] [Abstract][Full Text] [Related]
27. Superoxide Dismutase 1 (SOD1)-Derived Peptide Inhibits Amyloid Aggregation of Familial Amyotrophic Lateral Sclerosis SOD1 Mutants.
Banerjee V; Shani T; Katzman B; Vyazmensky M; Papo N; Israelson A; Engel S
ACS Chem Neurosci; 2016 Nov; 7(11):1595-1606. PubMed ID: 27540759
[TBL] [Abstract][Full Text] [Related]
28. Identification of a misfolded region in superoxide dismutase 1 that is exposed in amyotrophic lateral sclerosis.
Rotunno MS; Auclair JR; Maniatis S; Shaffer SA; Agar J; Bosco DA
J Biol Chem; 2014 Oct; 289(41):28527-38. PubMed ID: 25164820
[TBL] [Abstract][Full Text] [Related]
29. ERp57 is protective against mutant SOD1-induced cellular pathology in amyotrophic lateral sclerosis.
Parakh S; Jagaraj CJ; Vidal M; Ragagnin AMG; Perri ER; Konopka A; Toth RP; Galper J; Blair IP; Thomas CJ; Walker AK; Yang S; Spencer DM; Atkin JD
Hum Mol Genet; 2018 Apr; 27(8):1311-1331. PubMed ID: 29409023
[TBL] [Abstract][Full Text] [Related]
30. Rab1-dependent ER-Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS.
Soo KY; Halloran M; Sundaramoorthy V; Parakh S; Toth RP; Southam KA; McLean CA; Lock P; King A; Farg MA; Atkin JD
Acta Neuropathol; 2015 Nov; 130(5):679-97. PubMed ID: 26298469
[TBL] [Abstract][Full Text] [Related]
31. Heat shock protein Grp78/BiP/HspA5 binds directly to TDP-43 and mitigates toxicity associated with disease pathology.
François-Moutal L; Scott DD; Ambrose AJ; Zerio CJ; Rodriguez-Sanchez M; Dissanayake K; May DG; Carlson JM; Barbieri E; Moutal A; Roux KJ; Shorter J; Khanna R; Barmada SJ; McGurk L; Khanna M
Sci Rep; 2022 May; 12(1):8140. PubMed ID: 35581326
[TBL] [Abstract][Full Text] [Related]
32. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
Hayashi Y; Homma K; Ichijo H
Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
[TBL] [Abstract][Full Text] [Related]
33. The prion-like nature of amyotrophic lateral sclerosis.
McAlary L; Yerbury JJ; Cashman NR
Prog Mol Biol Transl Sci; 2020; 175():261-296. PubMed ID: 32958236
[TBL] [Abstract][Full Text] [Related]
34. Molecular chaperone mediated late-stage neuroprotection in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Novoselov SS; Mustill WJ; Gray AL; Dick JR; Kanuga N; Kalmar B; Greensmith L; Cheetham ME
PLoS One; 2013; 8(8):e73944. PubMed ID: 24023695
[TBL] [Abstract][Full Text] [Related]
35. Does wild-type Cu/Zn-superoxide dismutase have pathogenic roles in amyotrophic lateral sclerosis?
Furukawa Y; Tokuda E
Transl Neurodegener; 2020 Aug; 9(1):33. PubMed ID: 32811540
[TBL] [Abstract][Full Text] [Related]
36. Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis?
Kabashi E; Valdmanis PN; Dion P; Rouleau GA
Ann Neurol; 2007 Dec; 62(6):553-9. PubMed ID: 18074357
[TBL] [Abstract][Full Text] [Related]
37. Misfolded SOD1 is not a primary component of sporadic ALS.
Da Cruz S; Bui A; Saberi S; Lee SK; Stauffer J; McAlonis-Downes M; Schulte D; Pizzo DP; Parone PA; Cleveland DW; Ravits J
Acta Neuropathol; 2017 Jul; 134(1):97-111. PubMed ID: 28247063
[TBL] [Abstract][Full Text] [Related]
38. Co-chaperone CHIP associates with mutant Cu/Zn-superoxide dismutase proteins linked to familial amyotrophic lateral sclerosis and promotes their degradation by proteasomes.
Choi JS; Cho S; Park SG; Park BC; Lee DH
Biochem Biophys Res Commun; 2004 Aug; 321(3):574-83. PubMed ID: 15358145
[TBL] [Abstract][Full Text] [Related]
39. Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis.
Seetharaman SV; Prudencio M; Karch C; Holloway SP; Borchelt DR; Hart PJ
Exp Biol Med (Maywood); 2009 Oct; 234(10):1140-54. PubMed ID: 19596823
[TBL] [Abstract][Full Text] [Related]
40. Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1.
Kim SH; Shi Y; Hanson KA; Williams LM; Sakasai R; Bowler MJ; Tibbetts RS
J Biol Chem; 2009 Mar; 284(12):8083-92. PubMed ID: 19112176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
